Study on the degradation of 3D printed silk fibroin/polyvinyl alcohol/nano hydroxyapatite scaffold in vivo
2021, 41(11):
966-971.
Abstract
(
1 )
References |
Related Articles |
Metrics
Objective To study and discuss the degradation performance of SF/PVA/n-HA and PVA/n-HA scaffolds, we used 3D printing technology to print silk fibroin/polyvinyl alcohol/nanohydroxyapatite scaffold and polyvinyl alcohol/nanohydroxyapatite scaffold with cell membrane and then replanted them in animals. Methods The SF/PVA/n-HA scaffold and PVA/n-HA scaffold were respectively implanted into the mandible of sheep. The experimental animals were sacrificed at 1, 2, and 3 months after surgery. The mandible where the stent was located was taken out, and radiographic observation, HE staining observation, and realtime quantitative PCR(RT-PCR) detection were performed to explore the difference between the degradation of the two stents in vivo and the relationship between degradation related factors. Results ①Radiographic results:the lowdensity shadows at the bone defect in the SF/PVA/n-HA stent group and PVA/n-HA stent reduced, and the lowdensity shadows in the SF/PVA/n-HA stent group were smaller. The highdensity shadow area is also more obvious in the SF/PVA/n-HA stent group than the PVA/n-HA stent group. ② HE staining results:in the SF/PVA/n-HA scaffold group, some stent remnants were still visible in the first two months, and inflammatory cells were detected around the scaffold in the first two months. The inflammation gradually subsided at the end of the third month and obvious bone lacuna was seen. ③RT-PCR:comparing different materials at the same time, the SF/PVA/n-HA stent group and PVA/n-HA stent group were compared with the patch group respectively (P<0.05). The differences were statistically significant. Comparing the SF/PVA/n-HA stent group with the PVA/n-HA scaffold group, the expression trends of the four factors IL-1, IL-6, M-CSF, and NFATc1 were similar. At 1, 2 months after surgery, the mRNA expression levels of the four factors in the SF/PVA/n-HA scaffold group were higher than those in the PVA/n-HA scaffold group; at 3 months after surgery, the mRNA expression levels of the four factors in the SF/PVA/n-HA scaffold group were lower than the PVA/n-HA stent group (P<0.05).
Conclusion The SF/PVA/n-HA scaffold has certain degradation properties, and during the degradation process, it can promote the expression of osteoclastrelated factors IL-1, IL-6, M-CSF, and NFATc1.